Sign up
Login
Friday 1st March 2019
13:45 Welcome and introduction (D. Betticher, Fribourg)
Targeted therapies, state of the art (D. Betticher, Fribourg)
13:50 EGFR (J. Yang, Taiwan)
14:20 ALK (M. Früh, St. Gallen)
14:50 Others (RAF, ROS, RET) (O. Gautschi, Luzern)
15:20 Case presentations
16:00 Coffee break
Diagnostics (R. Stahel, Zürich)
16:30 Pathology: Identifying targets in lung cancer (I. Letovanec, Lausanne)
17:00 Genomics: present state (L. Bubendorf, Basel)
17:30 Predictors for IO/Immunogram (J. Haanen, Amsterdam)
18:10 Discussion
18:30 Adjourn
Saturday 2nd March 2019
Immunotherapy (D. Betticher, Fribourg)
08:00 Frontline IO for all? (S. Peters, Lausanne)
08:30 IO for early NSCLC (D. Planchard, Villejuif Cedex)
09:00 New developments (phase I) (S. Zimmermann, Lausanne)
09:30 Case presentations
10:00 Coffee break
Further situations (S. Peters, Lausanne)
10:30 IO for Mesothelioma and SCKC (N. Girard, Paris)
11:00 Other new options for Mesothelioma and SCLC (M. Pless, Winterthur)
11:30 Oligometastastic disease (N. Andratschke, Zürich)
12:00 Wrap up (S. Peters, R. Stahel)
12:15 End